Clinical Trials Browser

Myasthenia Gravis

Autoimmune Diseases, Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Myasthenia Gravis

Clinical Trials

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

ziMyG+

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

EPIC

A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

RELIEVE

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

MyVision

A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

MINT

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

RAISE-XT

NIMBLE

ADAPTSC+

ECU-MG-304

A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

ADAPT oculus

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

ADAPT NXT

ADAPT SERON

URSA

An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

RAISE

Study of Telitacicept in Generalized Myasthenia Gravis

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)

Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

ADAPT+

MG

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

ADAPTsc

ADAPT

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients